Posted by Surbhi on July 09 2026 at 06:02 PM
public
IL-23 inhibitors in IBD treatment — the selective biologics targeting the p19 subunit of interleukin-23 (risankizumab/Skyrizi, guselkumab/Tremfya, mirikizumab/Omvoh) demonstrating superior effica...
